Anticancer efficacy of the hypoxia‐activated prodrug evofosfamide (TH‐302) in osteolytic breast cancer murine models
Vasilios Liapis(Basil Hetzel Institute), Andreas Evdokiou(Royal Adelaide Hospital)
Cited by 30
Related Papers
Peroxidase Enzymes Regulate Collagen Extracellular Matrix Biosynthesis
|American Journal Of Pathology|2015|35
Near-Infrared Photoimmunotherapy Using a Small Protein Mimetic for HER2-Overexpressing Breast Cancer
|International Journal of Molecular Sciences|2019|30
Anti-tumor and anti-osteolysis effects of the metronomic use of zoledronic acid in primary and metastatic breast cancer mouse models
|Cancer Letters|2013|13
Targeting Cancer in the Bone with the Hypoxia Activated Pro-Drug Evofosfamide
|Adelaide Research & Scholarship (AR&S) (University of Adelaide)|2017|0